Drug Shortage Report for TEVA-TECNAL C 1/4
| Report ID | 98741 |
| Drug Identification Number | 00608203 |
| Brand name | TEVA-TECNAL C 1/4 |
| Common or Proper name | TECNAL C-1/4 CAPSULES |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ACETYLSALICYLIC ACID BUTALBITAL CODEINE PHOSPHATE CAFFEINE |
| Strength(s) | 330MG 50MG 15MG 40MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-11-13 |
| Estimated end date | 2020-03-31 |
| Actual end date | 2020-02-06 |
| Shortage status | Resolved |
| Updated date | 2020-02-07 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.